Stimcell Energetics Inc.
STMEBusiness Summary
Stimcell Energetics Inc. is a biotech company focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness and alleviate health complications, including, but not limited to: aging, insulin sensitivity, high blood pressure, neuropathy and kidney function. The Company’s primary focus is on continued research and development of its eBalance® Technology and its eBalance® Home System. The market for treatments that assist in the control and management of diabetes, its complications, as well as other ailments, including pain management, is highly competitive. According to information published by the International Diabetes Federation in its IDF Diabetes Atlas Tenth Edition (2021), in 2021, approximately 537 million adults (20-79 years) were living with diabetes; by 2045 this will rise to 783 million, and a further 541 million people are at an increased risk of developing Type 2 diabetes.
The Company operates in a highly competitive market, facing competition from large, well established medical device manufacturers and pharmaceutical companies in the market for treatment of pain and management of diabetes and related ailments. The Company competes indirectly with pharmaceutical and medical device companies, such as Bayer Corp., Becton Dickinson Corp., LifeScan Inc., a division of Johnson & Johnson, the MediSense Inc., and TheraSense Inc. Since the Company’s eBalance® Pro and eBalance® Home Systems are based on microcurrent therapy, which is not yet widely accepted in traditional medicine, direct competition for these Systems is not well defined. The Company’s eBalance® Technology is not patented, but the Company holds registered trademarks for EBALANCE in Canada, the European Union, the U.K., and the United States.
The Company generates revenue through the sale of its eBalance® medical device systems, specifically the eBalance® Pro System for healthcare professionals in a clinical setting and the eBalance® Home System for patients to manage their symptoms at home. The Company also previously generated monthly recurring revenue from the online sales of eBalance® treatment packages, but suspended all revenue-generating activities associated with sales of eBalance® Home and Pro Systems following the cancellation of its Health Canada Class II Medical Device Licenses. During the years ended May 31, 2026 and 2025, the Company did not generate any revenue.
The eBalance® Technology is based on the science of bioelectric signals, their effect on epigenetic events within the human body, and ability to modify and affect the behavior of cells, tissues, and organs. The eBalance® Technology utilizes microcurrent electrical therapy to deliver subsensory micro amperage current to the patient/user to support general wellness or provide temporary relief of pain. The eBalance® Pro System is designed for Professional Use by Healthcare practitioners in a clinical setting, with treatments administered using Hand Bars, Foot Plates, and/or Pen Probes. The eBalance® Home System is for Home Use and will be available without a prescription, with treatments administered using Hand Bars and Foot Plates and controlled by the eBalance® Console. Both systems are intended to be used for temporary relief of pain associated with sore-aching muscles in the shoulder, waist, back, neck, upper and lower extremities (arms and legs) due to strain from exercise or normal household work activities and general activities of daily living.
In February 2025, the Company established a new partnership with ADM Tronics Unlimited, Inc., a leader in electronic medical device engineering, to redesign the eBalance® Home device into a compact, affordable consumer unit optimized for home use, complete with diagnostic features. The new eBalance® Home system is expected to be redesigned as a smaller and more cost-efficient unit than its predecessor, making advanced microcurrent technology accessible to a broader audience. Additionally, it will feature innovative diagnostics, including a real-time assessment of cellular energy capacity, treatment tracking, and personalized user profiles. The wellness designation of the new device will negate the process of seeking approval for a medical device from the FDA and speed up the time required to reach market and lower the cost. This new streamlined unit is expected to be completed in the fall of 2025 and ready for market in early 2026. On December 1, 2025, the Company entered into a service agreement to conduct a study examining the effects of the eBalance® microcurrent device, which was expected to last three months and cost approximately $27,100.
During the year ended May 31, 2026, the Company issued 750,000 shares valued at $250,000 under an agreement with an investor relations and public relations firm, and on March 19, 2026, issued 250,000 shares valued at $75,025 under an advisory services agreement with Stonegate Capital Partners, Inc. The Company also borrowed $200,000 from Mr. Richard Jeffs and $100,582 from Mrs. Susan Jeffs during the year. On July 16, 2026, subsequent to fiscal year end, the Company amended the terms of its unsecured line of credit agreement with Mr. Richard Jeffs, increasing the borrowing limit from $200,000 to $350,000, and borrowed an additional $50,000 under this line of credit, with Mr. Jeffs also advancing CAD$85,000 under the existing CAD$100,000 line of credit.
The Company’s net loss for the year ended May 31, 2026 was $895,375, compared to a net loss of $566,293 for the year ended May 31, 2025, an increase of 58.1%. Total operating expenses increased by 58.2% from $522,106 to $826,027. The Company had a cash balance of $3,057, a working capital deficit of $1,811,320, and cash flows used in operations of $312,081 for the year then ended. As of May 31, 2026, the Company had accumulated a deficit of $11,756,931 since inception.
Business Outlook
Management expects elevated research and development expenditures to continue in the near term as development progresses on the redesign of the eBalance® Home device with ADM Tronics Unlimited, Inc. The project is expected to span approximately nine months, and management is planning to support its operations as well as redesign of the eBalance® microcurrent device through equity or debt financing.
The Company’s primary growth vector is the redesign of the eBalance® Home device into a compact, affordable consumer unit optimized for home use, complete with diagnostic features, in partnership with ADM Tronics Unlimited, Inc. The new eBalance® Home system is expected to be a smaller and more cost-efficient unit than its predecessor, making advanced microcurrent technology accessible to a broader audience. The wellness designation of the new device will negate the process of seeking approval for a medical device from the FDA and speed up the time required to reach market and lower the cost. This new streamlined unit is expected to be completed in the fall of 2025 and ready for market in early 2026.
The Company was considering developing more specialized software/treatment options to target other ailments such as gout, hypertension, heart disease, neurological disorders, and depression, among others, to capture a larger market share. However, the Company’s lack of funding and unfavorable financial position made it impossible to roll out such expansion, and management felt it necessary to stop all further research and development of eBalance® Technology until the Company is financially stable and has secured substantial financing to support its day-to-day operations and further research opportunities.
The Company’s research and development costs increased by 226.8% from $64,009 during the year ended May 31, 2025, to $209,176 during the year ended May 31, 2026, driven by the engagement of ADM Tronics Unlimited, Inc. to redesign the eBalance® Home device. Management expects elevated research and development expenditures to continue in the near term as development progresses.
The Company’s operations are funded through debt and equity financing, with no revenue generated during the years ended May 31, 2026 and 2025. During the year ended May 31, 2026, the Company funded its operations with $300,582 borrowed from its related parties at 10% annual interest compounded monthly and due on demand. The Company’s ability to continue operations is dependent on its ability to obtain additional financing and ultimately achieve profitable operations.
The Company does not have any share purchase options issued and exercisable as at May 31, 2026 and 2025. All warrants expired unexercised on March 12, 2026. The Company has not paid any cash dividends on its common stock since its inception and does not anticipate paying any cash dividends in the foreseeable future, planning to retain its earnings, if any, to provide funds for the expansion of its business.
The Company faces significant headwinds including a working capital deficiency of $1,811,320 as of May 31, 2026, and an accumulated deficit of $11,756,931 since inception. The Company must obtain additional capital, or its business will fail. The Company does not have immediate sources of financing, and there is no assurance that the Company will be able to generate sufficient cash from operations to repay the amounts owing under the outstanding notes and advances payable, or to service other debt obligations.
The Company is subject to numerous governmental regulations which can increase its costs of developing the eBalance® Technology and products based on this technology. The Company’s products are subject to rigorous regulation by the FDA, Health Canada and numerous international, supranational, federal, and state authorities. The process of obtaining regulatory approvals to market a medical device can be costly and time-consuming, and approvals may not be granted for future products, or additional indications or uses of existing products, on a timely basis, if at all.
Risk Factors
The Company has a working capital deficiency of $1,811,320 as of May 31, 2026, and an accumulated deficit of $11,756,931 since inception, raising substantial doubt about its ability to continue as a going concern. The Company must obtain additional capital, or its business will fail, and it does not have immediate sources of financing. As of May 31, 2026, the Company had approximately $1,498,798 in amounts due to related parties and notes payable, and if unable to repay these amounts when due, it may be required to settle the debt through the issuance of Common Shares, which would result in dilution to existing shareholders. The Company has previously settled related party debt through the issuance of Common Shares, including the conversion of $1,622,693 in outstanding debt into 15,454,221 Common Shares in December 2023. The Company’s products are subject to rigorous regulation by the FDA, Health Canada and numerous international, supranational, federal, and state authorities, and the process of obtaining regulatory approvals to market a medical device can be costly and time-consuming, and approvals may not be granted for future products, or additional indications or uses of existing products, on a timely basis, if at all. The Company’s eBalance® Technology is not patented, and an inability to defend, protect and enforce its intellectual property rights could adversely affect the financial results. The Company operates in a highly competitive market and faces competition from large, well established medical device manufacturers and pharmaceutical companies, many of which are very well accepted by health practitioners and have significant resources, and the Company may not be able to compete effectively.
Management Priorities
Management’s message emphasizes the Company’s focus on the discovery, development and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness and alleviate health complications. The Company’s primary focus is on continued research and development of its eBalance® Technology and its eBalance® Home System. Management highlights the engagement of ADM Tronics Unlimited, Inc. in February 2025 to redesign the eBalance® Home device into a compact, affordable consumer unit optimized for home use, complete with diagnostic features, with the project expected to span approximately nine months. Management is planning to support its operations as well as redesign of the eBalance® microcurrent device through equity or debt financing. The Company’s continuation as a going concern depends upon the continued financial support of its shareholders, its ability to obtain necessary debt or equity financing to continue operations, and the attainment of profitable operations.
View Source Annual Report on SEC.gov ↗
References
- [1] Item 1, Business — Market Opportunity
- [2] Item 1, Business — Market Opportunity
- [3] Item 1, Business — Market Opportunity
- [4] Item 1A, Risk Factors
- [5] Item 1, Business — Competition
- [6] Item 1, Business — Patents/Trademarks
- [7] Item 1, Business — Product Development
- [8] Item 1, Business — Product Development
- [9] Item 7, MD&A — Results of Operations
- [10] Item 7, MD&A — Results of Operations
- [11] Item 7, MD&A — Results of Operations
- [12] Item 7, MD&A — Results of Operations
- [13] Item 7, MD&A — Results of Operations
- [14] Item 7, MD&A — Results of Operations
- [15] Item 7, MD&A — Results of Operations
- [16] Item 7, MD&A — Results of Operations
- [17] Item 7, MD&A — Results of Operations
- [18] Item 7, MD&A — Results of Operations
- [19] Item 7, MD&A — Results of Operations
- [20] Item 7, MD&A — Results of Operations
- [21] Item 7, MD&A — Results of Operations
- [22] Item 7, MD&A — Results of Operations
- [23] Item 7, MD&A — Results of Operations
- [24] Item 7, MD&A — Results of Operations
- [25] Item 7, MD&A — Results of Operations
- [26] Item 7, MD&A — Results of Operations
- [27] Item 7, MD&A — Results of Operations
- [28] Item 7, MD&A — Results of Operations
- [29] Item 7, MD&A — Results of Operations
- [30] Item 7, MD&A — Results of Operations
- [31] Item 7, MD&A — Results of Operations
- [32] Item 7, MD&A — Results of Operations
- [33] Item 7, MD&A — Results of Operations
- [34] Item 7, MD&A — Results of Operations
- [35] Item 7, MD&A — Results of Operations
- [36] Item 7, MD&A — Results of Operations
- [37] Item 7, MD&A — Results of Operations
- [38] Item 7, MD&A — Results of Operations
- [39] Item 7, MD&A — Results of Operations
- [40] Item 7, MD&A — Results of Operations
- [41] Item 7, MD&A — Results of Operations
- [42] Item 7, MD&A — Results of Operations
- [43] Item 7, MD&A — Results of Operations
- [44] Item 7, MD&A — Results of Operations
- [45] Item 7, MD&A — Results of Operations
- [46] Item 7, MD&A — Results of Operations
- [47] Item 7, MD&A — Results of Operations
- [48] Item 7, MD&A — Results of Operations
- [49] Item 7, MD&A — Results of Operations
- [50] Item 7, MD&A — Results of Operations
- [51] Item 7, MD&A — Results of Operations
- [52] Item 7, MD&A — Results of Operations
- [53] Item 7, MD&A — Results of Operations
- [54] Item 7, MD&A — Results of Operations
- [55] Item 7, MD&A — Results of Operations
- [56] Item 7, MD&A — Results of Operations
- [57] Item 7, MD&A — Results of Operations
- [58] Item 7, MD&A — Results of Operations
- [59] Item 7, MD&A — Results of Operations
- [60] Item 7, MD&A — Results of Operations
- [61] Item 7, MD&A — Results of Operations
- [62] Item 7, MD&A — Results of Operations
- [63] Item 7, MD&A — Results of Operations
- [64] Item 7, MD&A — Results of Operations
- [65] Item 7, MD&A — Results of Operations
- [66] Item 7, MD&A — Results of Operations
- [67] Item 7, MD&A — Results of Operations
- [68] Item 7, MD&A — Results of Operations
- [69] Item 7, MD&A — Results of Operations
- [70] Item 7, MD&A — Results of Operations
- [71] Item 7, MD&A — Results of Operations
- [72] Item 7, MD&A — Results of Operations
- [73] Item 7, MD&A — Results of Operations
- [74] Item 7, MD&A — Results of Operations
- [75] Item 7, MD&A — Results of Operations
- [76] Item 7, MD&A — Results of Operations
- [77] Item 7, MD&A — Results of Operations
- [78] Item 7, MD&A — Results of Operations
- [79] Item 7, MD&A — Results of Operations
- [80] Item 7, MD&A — Results of Operations
- [81] Item 7, MD&A — Results of Operations
- [82] Item 7, MD&A — Results of Operations
- [83] Item 7, MD&A — Results of Operations
- [84] Item 7, MD&A — Results of Operations
- [85] Item 7, MD&A — Results of Operations
- [86] Item 7, MD&A — Results of Operations
- [87] Item 7, MD&A — Results of Operations
- [88] Item 7, MD&A — Results of Operations
- [89] Item 7, MD&A — Results of Operations
- [90] Item 7, MD&A — Results of Operations
- [91] Item 7, MD&A — Results of Operations
- [92] Item 7, MD&A — Results of Operations
- [93] Item 7, MD&A — Results of Operations
- [94] Item 7, MD&A — Results of Operations
- [95] Item 7, MD&A — Results of Operations
- [96] Item 7, MD&A — Results of Operations
- [97] Item 7, MD&A — Results of Operations
- [98] Item 7, MD&A — Results of Operations
- [99] Item 7, MD&A — Results of Operations
- [100] Item 7, MD&A — Results of Operations
- [101] Item 7, MD&A — Results of Operations
- [102] Item 7, MD&A — Results of Operations
- [103] Item 7, MD&A — Results of Operations
- [104] Item 7, MD&A — Results of Operations
- [105] Item 7, MD&A — Results of Operations
- [106] Item 7, MD&A — Results of Operations
- [107] Item 7, MD&A — Results of Operations
- [108] Item 7, MD&A — Results of Operations
- [109] Item 7, MD&A — Results of Operations
- [110] Item 7, MD&A — Results of Operations
- [111] Item 7, MD&A — Results of Operations
- [112] Item 7, MD&A — Results of Operations
- [113] Item 7, MD&A — Results of Operations
- [114] Item 7, MD&A — Results of Operations
- [115] Item 7, MD&A — Results of Operations
- [116] Item 7, MD&A — Results of Operations
- [117] Item 7, MD&A — Results of Operations
- [118] Item 7, MD&A — Results of Operations
- [119] Item 7, MD&A — Results of Operations
- [120] Item 7, MD&A — Results of Operations
- [121] Item 7, MD&A — Results of Operations
- [122] Item 7, MD&A — Results of Operations
- [123] Item 7, MD&A — Results of Operations
- [124] Item 7, MD&A — Results of Operations
- [125] Item 7, MD&A — Results of Operations
- [126] Item 7, MD&A — Results of Operations
- [127] Item 7, MD&A — Results of Operations
- [128] Item 7, MD&A — Results of Operations
- [129] Item 7, MD&A — Results of Operations
- [130] Item 7, MD&A — Results of Operations
- [131] Item 7, MD&A — Results of Operations
- [132] Item 7, MD&A — Results of Operations
- [133] Item 7, MD&A — Results of Operations
- [134] Item 7, MD&A — Results of Operations
- [135] Item 7, MD&A — Results of Operations
- [136] Item 7, MD&A — Results of Operations
- [137] Item 7, MD&A — Results of Operations
- [138] Item 7, MD&A — Results of Operations
- [139] Item 7, MD&A — Results of Operations
- [140] Item 7, MD&A — Results of Operations
- [141] Item 7, MD&A — Results of Operations
- [142] Item 7, MD&A — Results of Operations
- [143] Item 7, MD&A — Results of Operations
- [144] Item 7, MD&A — Results of Operations
- [145] Item 7, MD&A — Results of Operations
- [146] Item 7, MD&A — Results of Operations
- [147] Item 7, MD&A — Results of Operations
- [148] Item 7, MD&A — Results of Operations
- [149] Item 7, MD&A — Results of Operations
- [150] Item 7, MD&A — Results of Operations
- [151] Item 7, MD&A — Results of Operations
- [152] Item 7, MD&A — Results of Operations
- [153] Item 7, MD&A — Results of Operations
- [154] Item 7, MD&A — Results of Operations
- [155] Item 7, MD&A — Results of Operations
- [156] Item 7, MD&A — Results of Operations
- [157] Item 7, MD&A — Results of Operations
- [158] Item 7, MD&A — Results of Operations
- [159] Item 7, MD&A — Results of Operations
- [160] Item 7, MD&A — Results of Operations
- [161] Item 7, MD&A — Results of Operations
- [162] Item 7, MD&A — Results of Operations
- [163] Item 7, MD&A — Results of Operations
- [164] Item 7, MD&A — Results of Operations
- [165] Item 7, MD&A — Results of Operations
- [166] Item 7, MD&A — Results of Operations
- [167] Item 7, MD&A — Results of Operations
- [168] Item 7, MD&A — Results of Operations
- [169] Item 7, MD&A — Results of Operations
- [170] Item 7, MD&A — Results of Operations
- [171] Item 7, MD&A — Results of Operations
- [172] Item 7, MD&A — Results of Operations
- [173] Item 7, MD&A — Results of Operations
- [174] Item 7, MD&A — Results of Operations
- [175] Item 7, MD&A — Results of Operations
- [176] Item 7, MD&A — Results of Operations
- [177] Item 7, MD&A — Results of Operations
- [178] Item 7, MD&A — Results of Operations
- [179] Item 7, MD&A — Results of Operations
- [180] Item 7, MD&A — Results of Operations
- [181] Item 7, MD&A — Results of Operations
- [182] Item 7, MD&A — Results of Operations
- [183] Item 7, MD&A — Results of Operations
- [184] Item 7, MD&A — Results of Operations
- [185] Item 7, MD&A — Results of Operations
- [186] Item 7, MD&A — Results of Operations
- [187] Item 7, MD&A — Results of Operations
- [188] Item 7, MD&A — Results of Operations
- [189] Item 7, MD&A — Results of Operations
- [190] Item 7, MD&A — Results of Operations
- [191] Item 7, MD&A — Results of Operations
- [192] Item 7, MD&A — Results of Operations
- [193] Item 7, MD&A — Results of Operations
- [194] Item 7, MD&A — Results of Operations
- [195] Item 7, MD&A — Results of Operations
- [196] Item 7, MD&A — Results of Operations
- [197] Item 7, MD&A — Results of Operations
- [198] Item 7, MD&A — Results of Operations
- [199] Item 7, MD&A — Results of Operations
- [200] Item 7, MD&A — Results of Operations
- [201] Item 7, MD&A — Results of Operations
- [202] Item 7, MD&A — Results of Operations
- [203] Item 7, MD&A — Results of Operations
- [204] Item 7, MD&A — Results of Operations
- [205] Item 7, MD&A — Results of Operations
- [206] Item 7, MD&A — Results of Operations
- [207] Item 7, MD&A — Results of Operations
- [208] Item 7, MD&A — Results of Operations
- [209] Item 7, MD&A — Results of Operations
- [210] Item 7, MD&A — Results of Operations
- [211] Item 7, MD&A — Results of Operations
- [212] Item 7, MD&A — Results of Operations
- [213] Item 7, MD&A — Results of Operations
- [214] Item 7, MD&A — Results of Operations
- [215] Item 7, MD&A — Results of Operations
- [216] Item 7, MD&A — Results of Operations
- [217] Item 7, MD&A — Results of Operations
- [218] Item 7, MD&A — Results of Operations
- [219] Item 7, MD&A — Results of Operations
- [220] Item 7, MD&A — Results of Operations
- [221] Item 7, MD&A — Results of Operations
- [222] Item 7, MD&A — Results of Operations
- [223] Item 7, MD&A — Results of Operations
- [224] Item 7, MD&A — Results of Operations
- [225] Item 7, MD&A — Results of Operations
- [226] Item 7, MD&A — Results of Operations
- [227] Item 7, MD&A — Results of Operations
- [228] Item 7, MD&A — Results of Operations
- [229] Item 7, MD&A — Results of Operations
- [230] Item 7, MD&A — Results of Operations
- [231] Item 7, MD&A — Results of Operations
- [232] Item 7, MD&A — Results of Operations
- [233] Item 7, MD&A — Results of Operations
- [234] Item 7, MD&A — Results of Operations
- [235] Item 7, MD&A — Results of Operations
- [236] Item 7, MD&A — Results of Operations
- [237] Item 7, MD&A — Results of Operations
- [238] Item 7, MD&A — Results of Operations
- [239] Item 7, MD&A — Results of Operations
- [240] Item 7, MD&A — Results of Operations
- [241] Item 7, MD&A — Results of Operations
- [242] Item 7, MD&A — Results of Operations
- [243] Item 7, MD&A — Results of Operations
- [244] Item 7, MD&A — Results of Operations
- [245] Item 7, MD&A — Results of Operations
- [246] Item 7, MD&A — Results of Operations
- [247] Item 7, MD&A — Results of Operations
- [248] Item 7, MD&A — Results of Operations
- [249] Item 7, MD&A — Results of Operations
- [250] Item 7, MD&A — Results of Operations
- [251] Item 7, MD&A — Results of Operations
- [252] Item 7, MD&A — Results of Operations
- [253] Item 7, MD&A — Results of Operations
- [254] Item 7, MD&A — Results of Operations
- [255] Item 7, MD&A — Results of Operations
- [256] Item 7, MD&A — Results of Operations
- [257] Item 7, MD&A — Results of Operations
- [258] Item 7, MD&A — Results of Operations
- [259] Item 7, MD&A — Results of Operations
- [260] Item 7, MD&A — Results of Operations
- [261] Item 7, MD&A — Results of Operations
- [262] Item 7, MD&A — Results of Operations
- [263] Item 7, MD&A — Results of Operations
- [264] Item 7, MD&A — Results of Operations
- [265] Item 7, MD&A — Results of Operations
- [266] Item 7, MD&A — Results of Operations
- [267] Item 7, MD&A — Results of Operations
- [268] Item 7, MD&A — Results of Operations
- [269] Item 7, MD&A — Results of Operations
- [270] Item 7, MD&A — Results of Operations
- [271] Item 7, MD&A — Results of Operations
- [272] Item 7, MD&A — Results of Operations
- [273] Item 7, MD&A — Results of Operations
- [274] Item 7, MD&A — Results of Operations
- [275] Item 7, MD&A — Results of Operations
- [276] Item 7, MD&A — Results of Operations
- [277] Item 7, MD&A — Results of Operations
- [278] Item 7, MD&A — Results of Operations
- [279] Item 7, MD&A — Results of Operations
- [280] Item 7, MD&A — Results of Operations
- [281] Item 7, MD&A — Results of Operations
- [282] Item 7, MD&A — Results of Operations
- [283] Item 7, MD&A — Results of Operations
- [284] Item 7, MD&A — Results of Operations
- [285] Item 7, MD&A — Results of Operations
- [286] Item 7, MD&A — Results of Operations
- [287] Item 7, MD&A — Results of Operations
- [288] Item 7, MD&A — Results of Operations
- [289] Item 7, MD&A — Results of Operations
- [290] Item 7, MD&A — Results of Operations
- [291] Item 7, MD&A — Results of Operations
- [292] Item 7, MD&A — Results of Operations
- [293] Item 7, MD&A — Results of Operations
- [294] Item 7, MD&A — Results of Operations
- [295] Item 7, MD&A — Results of Operations
- [296] Item 7, MD&A — Results of Operations
- [297] Item 7, MD&A — Results of Operations
- [298] Item 7, MD&A — Results of Operations
- [299] Item 7, MD&A — Results of Operations
- [300] Item 7, MD&A — Results of Operations
- [301] Item 7, MD&A — Results of Operations
- [302] Item 7, MD&A — Results of Operations
- [303] Item 7, MD&A — Results of Operations
- [304] Item 7, MD&A — Results of Operations
- [305] Item 7, MD&A — Results of Operations
- [306] Item 7, MD&A — Results of Operations
- [307] Item 7, MD&A — Results of Operations
- [308] Item 7, MD&A — Results of Operations
- [309] Item 7, MD&A — Results of Operations
- [310] Item 7, MD&A — Results of Operations
- [311] Item 7, MD&A — Results of Operations
- [312] Item 7, MD&A — Results of Operations
- [313] Item 7, MD&A — Results of Operations
- [314] Item 7, MD&A — Results of Operations
- [315] Item 7, MD&A — Results of Operations
- [316] Item 7, MD&A — Results of Operations
- [317] Item 7, MD&A — Results of Operations
- [318] Item 7, MD&A — Results of Operations
- [319] Item 7, MD&A — Results of Operations
- [320] Item 7, MD&A — Results of Operations
- [321] Item 7, MD&A — Results of Operations
- [322] Item 7, MD&A — Results of Operations
- [323] Item 7, MD&A — Results of Operations
- [324] Item 7, MD&A — Results of Operations
- [325] Item 7, MD&A — Results of Operations
- [326] Item 7, MD&A — Results of Operations
- [327] Item 7, MD&A — Results of Operations
- [328] Item 7, MD&A — Results of Operations
- [329] Item 7, MD&A — Results of Operations
- [330] Item 7, MD&A — Results of Operations
- [331] Item 7, MD&A — Results of Operations
- [332] Item 7, MD&A — Results of Operations
- [333] Item 7, MD&A — Results of Operations
- [334] Item 7, MD&A — Results of Operations
- [335] Item 7, MD&A — Results of Operations
- [336] Item 7, MD&A — Results of Operations
- [337] Item 7, MD&A — Results of Operations
- [338] Item 7, MD&A — Results of Operations
- [339] Item 7, MD&A — Results of Operations
- [340] Item 7, MD&A — Results of Operations
- [341] Item 7, MD&A — Results of Operations
- [342] Item 7, MD&A — Results of Operations
- [343] Item 7, MD&A — Results of Operations
- [344] Item 7, MD&A — Results of Operations
- [345] Item 7, MD&A — Results of Operations
- [346] Item 7, MD&A — Results of Operations
- [347] Item 7, MD&A — Results of Operations
- [348] Item 7, MD&A — Results of Operations
- [349] Item 7, MD&A — Results of Operations
- [350] Item 7, MD&A — Results of Operations
- [351] Item 7, MD&A — Results of Operations
- [352] Item 7, MD&A — Results of Operations
- [353] Item 7, MD&A — Results of Operations
- [354] Item 7, MD&A — Results of Operations
- [355] Item 7, MD&A — Results of Operations
- [356] Item 7, MD&A — Results of Operations
- [357] Item 7, MD&A — Results of Operations
- [358] Item 7, MD&A — Results of Operations
- [359] Item 7, MD&A — Results of Operations
- [360] Item 7, MD&A — Results of Operations
- [361] Item 7, MD&A — Results of Operations
- [362] Item 7, MD&A — Results of Operations
- [363] Item 7, MD&A — Results of Operations
- [364] Item 7, MD&A — Results of Operations
- [365] Item 7, MD&A — Results of Operations
- [366] Item 7, MD&A — Results of Operations
- [367] Item 7, MD&A — Results of Operations
- [368] Item 7, MD&A — Results of Operations
- [369] Item 7, MD&A — Results of Operations
- [370] Item 7, MD&A — Results of Operations
- [371] Item 7, MD&A — Results of Operations
- [372] Item 7, MD&A — Results of Operations
- [373] Item 7, MD&A — Results of Operations
- [374] Item 7, MD&A — Results of Operations
- [375] Item 7, MD&A — Results of Operations
- [376] Item 7, MD&A — Results of Operations
- [377] Item 7, MD&A — Results of Operations
- [378] Item 7, MD&A — Results of Operations
- [379] Item 7, MD&A — Results of Operations
- [380] Item 7, MD&A — Results of Operations
- [381] Item 7, MD&A — Results of Operations
- [382] Item 7, MD&A — Results of Operations
- [383] Item 7, MD&A — Results of Operations
- [384] Item 7, MD&A — Results of Operations
- [385] Item 7, MD&A — Results of Operations
- [386] Item 7, MD&A — Results of Operations
- [387] Item 7, MD&A — Results of Operations
- [388] Item 7, MD&A — Results of Operations
- [389] Item 7, MD&A — Results of Operations
- [390] Item 7, MD&A — Results of Operations
- [391] Item 7, MD&A — Results of Operations
- [392] Item 7, MD&A — Results of Operations
- [393] Item 7, MD&A — Results of Operations
- [394] Item 7, MD&A — Results of Operations
- [395] Item 7, MD&A — Results of Operations
- [396] Item 7, MD&A — Results of Operations
- [397] Item 7, MD&A — Results of Operations
- [398] Item 7, MD&A — Results of Operations
- [399] Item 7, MD&A — Results of Operations
- [400] Item 7, MD&A — Results of Operations
- [401] Item 7, MD&A — Results of Operations
- [402] Item 7, MD&A — Results of Operations
- [403] Item 7, MD&A — Results of Operations
- [404] Item 7, MD&A — Results of Operations
- [405] Item 7, MD&A — Results of Operations
- [406] Item 7, MD&A — Results of Operations
- [407] Item 7, MD&A — Results of Operations
- [408] Item 7, MD&A — Results of Operations
- [409] Item 7, MD&A — Results of Operations
- [410] Item 7, MD&A — Results of Operations
- [411] Item 7, MD&A — Results of Operations
- [412] Item 7, MD&A — Results of Operations
- [413] Item 7, MD&A — Results of Operations
- [414] Item 7, MD&A — Results of Operations
- [415] Item 7, MD&A — Results of Operations
- [416] Item 7, MD&A — Results of Operations
- [417] Item 7, MD&A — Results of Operations
- [418] Item 7, MD&A — Results of Operations
- [419] Item 7, MD&A — Results of Operations
- [420] Item 7, MD&A — Results of Operations
- [421] Item 7, MD&A — Results of Operations
- [422] Item 7, MD&A — Results of Operations
- [423] Item 7, MD&A — Results of Operations
- [424] Item 7, MD&A — Results of Operations
- [425] Item 7, MD&A — Results of Operations
- [426] Item 7, MD&A — Results of Operations
- [427] Item 7, MD&A — Results of Operations
- [428] Item 7, MD&A — Results of Operations
- [429] Item 7, MD&A — Results of Operations
- [430] Item 7, MD&A — Results of Operations
- [431] Item 7, MD&A — Results of Operations
- [432] Item 7, MD&A — Results of Operations
- [433] Item 7, MD&A — Results of Operations
- [434] Item 7, MD&A — Results of Operations
- [435] Item 7, MD&A — Results of Operations
- [436] Item 7, MD&A — Results of Operations
- [437] Item 7, MD&A — Results of Operations
- [438] Item 7, MD&A — Results of Operations
- [439] Item 7, MD&A — Results of Operations
- [440] Item 7, MD&A — Results of Operations
- [441] Item 7, MD&A — Results of Operations
- [442] Item 7, MD&A — Results of Operations
- [443] Item 7, MD&A — Results of Operations
- [444] Item 7, MD&A — Results of Operations
- [445] Item 7, MD&A — Results of Operations
- [446] Item 7, MD&A — Results of Operations
- [447] Item 7, MD&A — Results of Operations
- [448] Item 7, MD&A — Results of Operations
- [449] Item 7, MD&A — Results of Operations
- [450] Item 7, MD&A — Results of Operations
- [451] Item 7, MD&A — Results of Operations
- [452] Item 7, MD&A — Results of Operations
- [453] Item 7, MD&A — Results of Operations
- [454] Item 7, MD&A — Results of Operations
- [455] Item 7, MD&A — Results of Operations
- [456] Item 7, MD&A — Results of Operations
- [457] Item 7, MD&A — Results of Operations
- [458] Item 7, MD&A — Results of Operations
- [459] Item 7, MD&A — Results of Operations
- [460] Item 7, MD&A — Results of Operations
- [461] Item 7, MD&A — Results of Operations
- [462] Item 7, MD&A — Results of Operations
- [463] Item 7, MD&A — Results of Operations
- [464] Item 7, MD&A — Results of Operations
- [465] Item 7, MD&A — Results of Operations
- [466] Item 7, MD&A — Results of Operations
- [467] Item 7, MD&A — Results of Operations
- [468] Item 7, MD&A — Results of Operations
- [469] Item 7, MD&A — Results of Operations
- [470] Item 7, MD&A — Results of Operations
- [471] Item 7, MD&A — Results of Operations
- [472] Item 7, MD&A — Results of Operations
- [473] Item 7, MD&A — Results of Operations
- [474] Item 7, MD&A — Results of Operations
- [475] Item 7, MD&A — Results of Operations
- [476] Item 7, MD&A — Results of Operations
- [477] Item 7, MD&A — Results of Operations
- [478] Item 7, MD&A — Results of Operations
- [479] Item 7, MD&A — Results of Operations
- [480] Item 7, MD&A — Results of Operations
- [481] Item 7, MD&A — Results of Operations
- [482] Item 7, MD&A — Results of Operations
- [483] Item 7, MD&A — Results of Operations
- [484] Item 7, MD&A — Results of Operations
- [485] Item 7, MD&A — Results of Operations
- [486] Item 7, MD&A — Results of Operations
- [487] Item 7, MD&A — Results of Operations
- [488] Item 7, MD&A — Results of Operations
- [489] Item 7, MD&A — Results of Operations
- [490] Item 7, MD&A — Results of Operations
- [491] Item 7, MD&A — Results of Operations
- [492] Item 7, MD&A — Results of Operations
- [493] Item 7, MD&A — Results of Operations
- [494] Item 7, MD&A — Results of Operations
- [495] Item 7, MD&A — Results of Operations
- [496] Item 7, MD&A — Results of Operations
- [497] Item 7, MD&A — Results of Operations
- [498] Item 7, MD&A — Results of Operations
- [499] Item 7, MD&A — Results of Operations
- [500] Item 7, MD&A — Results of Operations
- [501] Item 7, MD&A — Results of Operations
- [502] Item 7, MD&A — Results of Operations
- [503] Item 7, MD&A — Results of Operations
- [504] Item 7, MD&A — Results of Operations
- [505] Item 7, MD&A — Results of Operations
- [506] Item 7, MD&A — Results of Operations
- [507] Item 7, MD&A — Results of Operations
- [508] Item 7, MD&A — Results of Operations
- [509] Item 7, MD&A — Results of Operations
- [510] Item 7, MD&A — Results of Operations
- [511] Item 7, MD&A — Results of Operations
- [512] Item 7, MD&A — Results of Operations
- [513] Item 7, MD&A — Results of Operations
- [514] Item 7, MD&A — Results of Operations
- [515] Item 7, MD&A — Results of Operations
- [516] Item 7, MD&A — Results of Operations
- [517] Item 7, MD&A — Results of Operations
- [518] Item 7, MD&A — Results of Operations
- [519] Item 7, MD&A — Results of Operations
- [520] Item 7, MD&A — Results of Operations
- [521] Item 7, MD&A — Results of Operations
- [522] Item 7, MD&A — Results of Operations
- [523] Item 7, MD&A — Results of Operations
- [524] Item 7, MD&A — Results of Operations
- [525] Item 7, MD&A — Results of Operations
- [526] Item 7, MD&A — Results of Operations
- [527] Item 7, MD&A — Results of Operations
- [528] Item 7, MD&A — Results of Operations
- [529] Item 7, MD&A — Results of Operations
- [530] Item 7, MD&A — Results of Operations
- [531] Item 7, MD&A — Results of Operations
- [532] Item 7, MD&A — Results of Operations
- [533] Item 7, MD&A — Results of Operations
- [534] Item 7, MD&A — Results of Operations
- [535] Item 7, MD&A — Results of Operations
- [536] Item 7, MD&A — Results of Operations
- [537] Item 7, MD&A — Results of Operations
- [538] Item 7, MD&A — Results of Operations
- [539] Item 7, MD&A — Results of Operations
- [540] Item 7, MD&A — Results of Operations
- [541] Item 7, MD&A — Results of Operations
- [542] Item 7, MD&A — Results of Operations
- [543] Item 7, MD&A — Results of Operations
- [544] Item 7, MD&A — Results of Operations
- [545] Item 7, MD&A — Results of Operations
- [546] Item 7, MD&A — Results of Operations
- [547] Item 7, MD&A — Results of Operations
- [548] Item 7, MD&A — Results of Operations
- [549] Item 7, MD&A — Results of Operations
- [550] Item 7, MD&A — Results of Operations
- [551] Item 7, MD&A — Results of Operations
- [552] Item 7, MD&A — Results of Operations
- [553] Item 7, MD&A — Results of Operations
- [554] Item 7, MD&A — Results of Operations
- [555] Item 7, MD&A — Results of Operations
- [556] Item 7, MD&A — Results of Operations
- [557] Item 7, MD&A — Results of Operations
- [558] Item 7, MD&A — Results of Operations
- [559] Item 7, MD&A — Results of Operations
- [560] Item 7, MD&A — Results of Operations
- [561] Item 7, MD&A — Results of Operations
- [562] Item 7, MD&A — Results of Operations
- [563] Item 7, MD&A — Results of Operations
- [564] Item 7, MD&A — Results of Operations
- [565] Item 7, MD&A — Results of Operations
- [566] Item 7, MD&A — Results of Operations
- [567] Item 7, MD&A — Results of Operations
- [568] Item 7, MD&A — Results of Operations
- [569] Item 7, MD&A — Results of Operations
- [570] Item 7, MD&A — Results of Operations
- [571] Item 7, MD&A — Results of Operations
- [572] Item 7, MD&A — Results of Operations
- [573] Item 7, MD&A — Results of Operations
- [574] Item 7, MD&A — Results of Operations
- [575] Item 7, MD&A — Results of Operations
- [576] Item 7, MD&A — Results of Operations
- [577] Item 7, MD&A — Results of Operations
- [578] Item 7, MD&A — Results of Operations
- [579] Item 7, MD&A — Results of Operations
- [580] Item 7, MD&A — Results of Operations
- [581] Item 7, MD&A — Results of Operations
- [582] Item 7, MD&A — Results of Operations
- [583] Item 7, MD&A — Results of Operations
- [584] Item 7, MD&A — Results of Operations
- [585] Item 7, MD&A — Results of Operations
- [586] Item 7, MD&A — Results of Operations
- [587] Item 7, MD&A — Results of Operations
- [588] Item 7, MD&A — Results of Operations
- [589] Item 7, MD&A — Results of Operations
- [590] Item 7, MD&A — Results of Operations
- [591] Item 7, MD&A — Results of Operations
- [592] Item 7, MD&A — Results of Operations
- [593] Item 7, MD&A — Results of Operations
- [594] Item 7, MD&A — Results of Operations
- [595] Item 7, MD&A — Results of Operations
- [596] Item 7, MD&A — Results of Operations
- [597] Item 7, MD&A — Results of Operations
- [598] Item 7, MD&A — Results of Operations
- [599] Item 7, MD&A — Results of Operations
- [600] Item 7, MD&A — Results of Operations
- [601] Item 7, MD&A — Results of Operations
- [602] Item 7, MD&A — Results of Operations
- [603] Item 7, MD&A — Results of Operations
- [604] Item 7, MD&A — Results of Operations
- [605] Item 7, MD&A — Results of Operations
- [606] Item 7, MD&A — Results of Operations
- [607] Item 7, MD&A — Results of Operations
- [608] Item 7, MD&A — Results of Operations
- [609] Item 7, MD&A — Results of Operations
- [610] Item 7, MD&A — Results of Operations
- [611] Item 7, MD&A — Results of Operations
- [612] Item 7, MD&A — Results of Operations
- [613] Item 7, MD&A — Results of Operations
- [614] Item 7, MD&A — Results of Operations
- [615] Item 7, MD&A — Results of Operations
- [616] Item 7, MD&A — Results of Operations
- [617] Item 7, MD&A — Results of Operations
- [618] Item 7, MD&A — Results of Operations
- [619] Item 7, MD&A — Results of Operations
- [620] Item 7, MD&A — Results of Operations
- [621] Item 7, MD&A — Results of Operations
- [622] Item 7, MD&A — Results of Operations
- [623] Item 7, MD&A — Results of Operations
- [624] Item 7, MD&A — Results of Operations
- [625] Item 7, MD&A — Results of Operations
- [626] Item 7, MD&A — Results of Operations
- [627] Item 7, MD&A — Results of Operations
- [628] Item 7, MD&A — Results of Operations
- [629] Item 7, MD&A — Results of Operations
- [630] Item 7, MD&A — Results of Operations
- [631] Item 7, MD&A — Results of Operations
- [632] Item 7, MD&A — Results of Operations
- [633] Item 7, MD&A — Results of Operations
- [634] Item 7, MD&A — Results of Operations
- [635] Item 7, MD&A — Results of Operations
- [636] Item 7, MD&A — Results of Operations
- [637] Item 7, MD&A — Results of Operations
- [638] Item 7, MD&A — Results of Operations
- [639] Item 7, MD&A — Results of Operations
- [640] Item 7, MD&A — Results of Operations
- [641] Item 7, MD&A — Results of Operations
- [642] Item 7, MD&A — Results of Operations
- [643] Item 7, MD&A — Results of Operations
- [644] Item 7, MD&A — Results of Operations
- [645] Item 7, MD&A — Results of Operations
- [646] Item 7, MD&A — Results of Operations
- [647] Item 7, MD&A — Results of Operations
- [648] Item 7, MD&A — Results of Operations
- [649] Item 7, MD&A — Results of Operations
- [650] Item 7, MD&A — Results of Operations
- [651] Item 7, MD&A — Results of Operations
- [652] Item 7, MD&A — Results of Operations
- [653] Item 7, MD&A — Results of Operations
- [654] Item 7, MD&A — Results of Operations
- [655] Item 7, MD&A — Results of Operations
- [656] Item 7, MD&A — Results of Operations
- [657] Item 7, MD&A — Results of Operations
- [658] Item 7, MD&A — Results of Operations
- [659] Item 7, MD&A — Results of Operations
- [660] Item 7, MD&A — Results of Operations
- [661] Item 7, MD&A — Results of Operations
- [662] Item 7, MD&A — Results of Operations
- [663] Item 7, MD&A — Results of Operations
- [664] Item 7, MD&A — Results of Operations
- [665] Item 7, MD&A — Results of Operations
- [666] Item 7, MD&A — Results of Operations
- [667] Item 7, MD&A — Results of Operations
- [668] Item 7, MD&A — Results of Operations
- [669] Item 7, MD&A — Results of Operations
- [670] Item 7, MD&A — Results of Operations
- [671] Item 7, MD&A — Results of Operations
- [672] Item 7, MD&A — Results of Operations
- [673] Item 7, MD&A — Results of Operations
- [674] Item 7, MD&A — Results of Operations
- [675] Item 7, MD&A — Results of Operations
- [676] Item 7, MD&A — Results of Operations
- [677] Item 7, MD&A — Results of Operations
- [678] Item 7, MD&A — Results of Operations
- [679] Item 7, MD&A — Results of Operations
- [680] Item 7, MD&A — Results of Operations
- [681] Item 7, MD&A — Results of Operations
- [682] Item 7, MD&A — Results of Operations
- [683] Item 7, MD&A — Results of Operations
- [684] Item 7, MD&A — Results of Operations
- [685] Item 7, MD&A — Results of Operations
- [686] Item 7, MD&A — Results of Operations
- [687] Item 7, MD&A — Results of Operations
- [688] Item 7, MD&A — Results of Operations
- [689] Item 7, MD&A — Results of Operations
- [690] Item 7, MD&A — Results of Operations
- [691] Item 7, MD&A — Results of Operations
- [692] Item 7, MD&A — Results of Operations
- [693] Item 7, MD&A — Results of Operations
- [694] Item 7, MD&A — Results of Operations
- [695] Item 7, MD&A — Results of Operations
- [696] Item 7, MD&A — Results of Operations
- [697] Item 7, MD&A — Results of Operations
- [698] Item 7, MD&A — Results of Operations
- [699] Item 7, MD&A — Results of Operations
- [700] Item 7, MD&A — Results of Operations
- [701] Item 7, MD&A — Results of Operations
- [702] Item 7, MD&A — Results of Operations
- [703] Item 7, MD&A — Results of Operations
- [704] Item 7, MD&A — Results of Operations
- [705] Item 7, MD&A — Results of Operations
- [706] Item 7, MD&A — Results of Operations
- [707] Item 7, MD&A — Results of Operations
- [708] Item 7, MD&A — Results of Operations
- [709] Item 7, MD&A — Results of Operations
- [710] Item 7, MD&A — Results of Operations
- [711] Item 7, MD&A — Results of Operations
- [712] Item 7, MD&A — Results of Operations
- [713] Item 7, MD&A — Results of Operations
- [714] Item 7, MD&A — Results of Operations
- [715] Item 7, MD&A — Results of Operations
- [716] Item 7, MD&A — Results of Operations
- [717] Item 7, MD&A — Results of Operations
- [718] Item 7, MD&A — Results of Operations
- [719] Item 7, MD&A — Results of Operations
- [720] Item 7, MD&A — Results of Operations
- [721] Item 7, MD&A — Results of Operations
- [722] Item 7, MD&A — Results of Operations
- [723] Item 7, MD&A — Results of Operations
- [724] Item 7, MD&A — Results of Operations
- [725] Item 7, MD&A — Results of Operations
- [726] Item 7, MD&A — Results of Operations
- [727] Item 7, MD&A — Results of Operations
- [728] Item 7, MD&A — Results of Operations
- [729] Item 7, MD&A — Results of Operations
- [730] Item 7, MD&A — Results of Operations
- [731] Item 7, MD&A — Results of Operations
- [732] Item 7, MD&A — Results of Operations
- [733] Item 7, MD&A — Results of Operations
- [734] Item 7, MD&A — Results of Operations
- [735] Item 7, MD&A — Results of Operations
- [736] Item 7, MD&A — Results of Operations
- [737] Item 7, MD&A — Results of Operations
- [738] Item 7, MD&A — Results of Operations
- [739] Item 7, MD&A — Results of Operations
- [740] Item 7, MD&A — Results of Operations
- [741] Item 7, MD&A — Results of Operations
- [742] Item 7, MD&A — Results of Operations
- [743] Item 7, MD&A — Results of Operations
- [744] Item 7, MD&A — Results of Operations
- [745] Item 7, MD&A — Results of Operations
- [746] Item 7, MD&A — Results of Operations
- [747] Item 7, MD&A — Results of Operations
- [748] Item 7, MD&A — Results of Operations
- [749] Item 7, MD&A — Results of Operations
- [750] Item 7, MD&A — Results of Operations
- [751] Item 7, MD&A — Results of Operations
- [752] Item 7, MD&A — Results of Operations
- [753] Item 7, MD&A — Results of Operations
- [754] Item 7, MD&A — Results of Operations
- [755] Item 7, MD&A — Results of Operations
- [756] Item 7, MD&A — Results of Operations
- [757] Item 7, MD&A — Results of Operations
- [758] Item 7, MD&A — Results of Operations
- [759] Item 7, MD&A — Results of Operations
- [760] Item 7, MD&A — Results of Operations
- [761] Item 7, MD&A — Results of Operations
- [762] Item 7, MD&A — Results of Operations
- [763] Item 7, MD&A — Results of Operations
- [764] Item 7, MD&A — Results of Operations
- [765] Item 7, MD&A — Results of Operations
- [766] Item 7, MD&A — Results of Operations
- [767] Item 7, MD&A — Results of Operations
- [768] Item 7, MD&A — Results of Operations
- [769] Item 7, MD&A — Results of Operations
- [770] Item 7, MD&A — Results of Operations
- [771] Item 7, MD&A — Results of Operations
- [772] Item 7, MD&A — Results of Operations
- [773] Item 7, MD&A — Results of Operations
- [774] Item 7, MD&A — Results of Operations
- [775] Item 7, MD&A — Results of Operations
- [776] Item 7, MD&A — Results of Operations
- [777] Item 7, MD&A — Results of Operations
- [778] Item 7, MD&A — Results of Operations
- [779] Item 7, MD&A — Results of Operations
- [780] Item 7, MD&A — Results of Operations
- [781] Item 7, MD&A — Results of Operations
- [782] Item 7, MD&A — Results of Operations
- [783] Item 7, MD&A — Results of Operations
- [784] Item 7, MD&A — Results of Operations
- [785] Item 7, MD&A — Results of Operations
- [786] Item 7, MD&A — Results of Operations
- [787] Item 7, MD&A — Results of Operations
- [788] Item 7, MD&A — Results of Operations
- [789] Item 7, MD&A — Results of Operations
- [790] Item 7, MD&A — Results of Operations
- [791] Item 7, MD&A — Results of Operations
- [792] Item 7, MD&A — Results of Operations
- [793] Item 7, MD&A — Results of Operations
- [794] Item 7, MD&A — Results of Operations
- [795] Item 7, MD&A — Results of Operations
- [796] Item 7, MD&A — Results of Operations
- [797] Item 7, MD&A — Results of Operations
- [798] Item 7, MD&A — Results of Operations
- [799] Item 7, MD&A — Results of Operations
- [800] Item 7, MD&A — Results of Operations
- [801] Item 7, MD&A — Results of Operations
- [802] Item 7, MD&A — Results of Operations
- [803] Item 7, MD&A — Results of Operations
- [804] Item 7, MD&A — Results of Operations
- [805] Item 7, MD&A — Results of Operations
- [806] Item 7, MD&A — Results of Operations
- [807] Item 7, MD&A — Results of Operations
- [808] Item 7, MD&A — Results of Operations
- [809] Item 7, MD&A — Results of Operations
- [810] Item 7, MD&A — Results of Operations
- [811] Item 7, MD&A — Results of Operations
- [812] Item 7, MD&A — Results of Operations
- [813] Item 7, MD&A — Results of Operations
- [814] Item 7, MD&A — Results of Operations
- [815] Item 7, MD&A — Results of Operations
- [816] Item 7, MD&A — Results of Operations
- [817] Item 7, MD&A — Results of Operations
- [818] Item 7, MD&A — Results of Operations
- [819] Item 7, MD&A — Results of Operations
- [820] Item 7, MD&A — Results of Operations
- [821] Item 7, MD&A — Results of Operations
- [822] Item 7, MD&A — Results of Operations
- [823] Item 7, MD&A — Results of Operations
- [824] Item 7, MD&A — Results of Operations
- [825] Item 7, MD&A — Results of Operations
- [826] Item 7, MD&A — Results of Operations
- [827] Item 7, MD&A — Results of Operations
- [828] Item 7, MD&A — Results of Operations
- [829] Item 7, MD&A — Results of Operations
- [830] Item 7, MD&A — Results of Operations
- [831] Item 7, MD&A — Results of Operations
- [832] Item 7, MD&A — Results of Operations
- [833] Item 7, MD&A — Results of Operations
- [834] Item 7, MD&A — Results of Operations
- [835] Item 7, MD&A — Results of Operations
- [836] Item 7, MD&A — Results of Operations
- [837] Item 7, MD&A — Results of Operations
- [838] Item 7, MD&A — Results of Operations
- [839] Item 7, MD&A — Results of Operations
- [840] Item 7, MD&A — Results of Operations
- [841] Item 7, MD&A — Results of Operations
- [842] Item 7, MD&A — Results of Operations
- [843] Item 7, MD&A — Results of Operations
- [844] Item 7, MD&A — Results of Operations
- [845] Item 7, MD&A — Results of Operations
- [846] Item 7, MD&A — Results of Operations
- [847] Item 7, MD&A — Results of Operations
- [848] Item 7, MD&A — Results of Operations
- [849] Item 7, MD&A — Results of Operations
- [850] Item 7, MD&A — Results of Operations
- [851] Item 7, MD&A — Results of Operations
- [852] Item 7, MD&A — Results of Operations
- [853] Item 7, MD&A — Results of Operations
- [854] Item 7, MD&A — Results of Operations
- [855] Item 7, MD&A — Results of Operations
- [856] Item 7, MD&A — Results of Operations
- [857] Item 7, MD&A — Results of Operations
- [858] Item 7, MD&A — Results of Operations
- [859] Item 7, MD&A — Results of Operations
- [860] Item 7, MD&A — Results of Operations
- [861] Item 7, MD&A — Results of Operations
- [862] Item 7, MD&A — Results of Operations
- [863] Item 7, MD&A — Results of Operations
- [864] Item 7, MD&A — Results of Operations
- [865] Item 7, MD&A — Results of Operations
- [866] Item 7, MD&A — Results of Operations
- [867] Item 7, MD&A — Results of Operations
- [868] Item 7, MD&A — Results of Operations
- [869] Item 7, MD&A — Results of Operations
- [870] Item 7, MD&A — Results of Operations
- [871] Item 7, MD&A — Results of Operations
- [872] Item 7, MD&A — Results of Operations
- [873] Item 7, MD&A — Results of Operations
- [874] Item 7, MD&A — Results of Operations
- [875] Item 7, MD&A — Results of Operations
- [876] Item 7, MD&A — Results of Operations
- [877] Item 7, MD&A — Results of Operations
- [878] Item 7, MD&A — Results of Operations
- [879] Item 7, MD&A — Results of Operations
- [880] Item 7, MD&A — Results of Operations
- [881] Item 7, MD&A — Results of Operations
- [882] Item 7, MD&A — Results of Operations
- [883] Item 7, MD&A — Results of Operations
- [884] Item 7, MD&A — Results of Operations
- [885] Item 7, MD&A — Results of Operations
- [886] Item 7, MD&A — Results of Operations
- [887] Item 7, MD&A — Results of Operations
- [888] Item 7, MD&A — Results of Operations
- [889] Item 7, MD&A — Results of Operations
- [890] Item 7, MD&A — Results of Operations
- [891] Item 7, MD&A — Results of Operations
- [892] Item 7, MD&A — Results of Operations
- [893] Item 7, MD&A — Results of Operations
- [894] Item 7, MD&A — Results of Operations
- [895] Item 7, MD&A — Results of Operations
- [896] Item 7, MD&A — Results of Operations
- [897] Item 7, MD&A — Results of Operations
- [898] Item 7, MD&A — Results of Operations
- [899] Item 7, MD&A — Results of Operations
- [900] Item 7, MD&A — Results of Operations
- [901] Item 7, MD&A — Results of Operations
- [902] Item 7, MD&A — Results of Operations
- [903] Item 7, MD&A — Results of Operations
- [904] Item 7, MD&A — Results of Operations
- [905] Item 7, MD&A — Results of Operations
- [906] Item 7, MD&A — Results of Operations
- [907] Item 7, MD&A — Results of Operations
- [908] Item 7, MD&A — Results of Operations
- [909] Item 7, MD&A — Results of Operations
- [910] Item 7, MD&A — Results of Operations
- [911] Item 7, MD&A — Results of Operations
- [912] Item 7, MD&A — Results of Operations
- [913] Item 7, MD&A — Results of Operations
- [914] Item 7, MD&A — Results of Operations
- [915] Item 7, MD&A — Results of Operations
- [916] Item 7, MD&A — Results of Operations
- [917] Item 7, MD&A — Results of Operations
- [918] Item 7, MD&A — Results of Operations
- [919] Item 7, MD&A — Results of Operations
- [920] Item 7, MD&A — Results of Operations
- [921] Item 7, MD&A — Results of Operations
- [922] Item 7, MD&A — Results of Operations
- [923] Item 7, MD&A — Results of Operations
- [924] Item 7, MD&A — Results of Operations
- [925] Item 7, MD&A — Results of Operations
- [926] Item 7, MD&A — Results of Operations
- [927] Item 7, MD&A — Results of Operations
- [928] Item 7, MD&A — Results of Operations
- [929] Item 7, MD&A — Results of Operations
- [930] Item 7, MD&A — Results of Operations
- [931] Item 7, MD&A — Results of Operations
- [932] Item 7, MD&A — Results of Operations
- [933] Item 7, MD&A — Results of Operations
- [934] Item 7, MD&A — Results of Operations
- [935] Item 7, MD&A — Results of Operations
- [936] Item 7, MD&A — Results of Operations
- [937] Item 7, MD&A — Results of Operations
- [938] Item 7, MD&A — Results of Operations
- [939] Item 7, MD&A — Results of Operations
- [940] Item 7, MD&A — Results of Operations
- [941] Item 7, MD&A — Results of Operations
- [942] Item 7, MD&A — Results of Operations
- [943] Item 7, MD&A — Results of Operations
- [944] Item 7, MD&A — Results of Operations
- [945] Item 7, MD&A — Results of Operations
- [946] Item 7, MD&A — Results of Operations
- [947] Item 7, MD&A — Results of Operations
- [948] Item 7, MD&A — Results of Operations
- [949] Item 7, MD&A — Results of Operations
- [950] Item 7, MD&A — Results of Operations
- [951] Item 7, MD&A — Results of Operations
- [952] Item 7, MD&A — Results of Operations
- [953] Item 7, MD&A — Results of Operations
- [954] Item 7, MD&A — Results of Operations
- [955] Item 7, MD&A — Results of Operations
- [956] Item 7, MD&A — Results of Operations
- [957] Item 7, MD&A — Results of Operations
- [958] Item 7, MD&A — Results of Operations
- [959] Item 7, MD&A — Results of Operations
- [960] Item 7, MD&A — Results of Operations
- [961] Item 7, MD&A — Results of Operations
- [962] Item 7, MD&A — Results of Operations
- [963] Item 7, MD&A — Results of Operations
- [964] Item 7, MD&A — Results of Operations
- [965] Item 7, MD&A — Results of Operations
- [966] Item 7, MD&A — Results of Operations
- [967] Item 7, MD&A — Results of Operations
- [968] Item 7, MD&A — Results of Operations
- [969] Item 7, MD&A — Results of Operations
- [970] Item 7, MD&A — Results of Operations
- [971] Item 7, MD&A — Results of Operations
- [972] Item 7, MD&A — Results of Operations
- [973] Item 7, MD&A — Results of Operations
- [974] Item 7, MD&A — Results of Operations
- [975] Item 7, MD&A — Results of Operations
- [976] Item 7, MD&A — Results of Operations
- [977] Item 7, MD&A — Results of Operations
- [978] Item 7, MD&A — Results of Operations
- [979] Item 7, MD&A — Results of Operations
- [980] Item 7, MD&A — Results of Operations
- [981] Item 7, MD&A — Results of Operations
- [982] Item 7, MD&A — Results of Operations
- [983] Item 7, MD&A — Results of Operations
- [984] Item 7, MD&A — Results of Operations
- [985] Item 7, MD&A — Results of Operations
- [986] Item 7, MD&A — Results of Operations
- [987] Item 7, MD&A — Results of Operations
- [988] Item 7, MD&A — Results of Operations
- [989] Item 7, MD&A — Results of Operations
- [990] Item 7, MD&A — Results of Operations
- [991] Item 7, MD&A — Results of Operations
- [992] Item 7, MD&A — Results of Operations
- [993] Item 7, MD&A — Results of Operations
- [994] Item 7, MD&A — Results of Operations
- [995] Item 7, MD&A — Results of Operations
- [996] Item 7, MD&A — Results of Operations
- [997] Item 7, MD&A — Results of Operations
- [998] Item 7, MD&A — Results of Operations
- [999] Item 7, MD&A — Results of Operations
- [1000] Item 7, MD&A — Results of Operations
Analysis on 8/31/2026